Preprint describes DNM1L GTPase effector domain deletion causing intermediate mitochondrial and peroxisomal defects

Four individuals sharing a recurrent DNM1L GTPase effector domain deletion show a phenotypic severity intermediate between milder GTPase domain variants and severe middle-domain encephalopathy, and reveal a potentially targetable metabolic vulnerability.

Published · AI-drafted summary based on 1 public source
Illustration for rare disease story
Illustrative image — not from the source article.
Share

A preprint posted to bioRxiv describes four individuals harbouring a recurrent deletion affecting the GTPase effector domain (GED) of DNM1L, the gene encoding dynamin-related protein 1 (DRP1). DRP1 is a key GTPase that regulates the fission of both mitochondria and peroxisomes, and pathogenic DNM1L variants are associated with a spectrum of neurodevelopmental and neurodegenerative disorders.

Existing genotype–phenotype correlations in DNM1L-related disease suggest that variants in the GTPase domain tend towards milder presentations, while middle-domain variants are associated with severe developmental and epileptic encephalopathy. The functional impact of GED variants had been less well defined. The authors characterise this recurrent GED deletion at the cellular level and find that it produces intermediate defects in both mitochondrial and peroxisomal dynamics — consistent with a phenotypic severity between the two previously described poles.

Notably, the study identifies a metabolic vulnerability associated with the GED deletion that the authors describe as potentially targetable, though further experimental and clinical work would be required before any therapeutic implications could be assessed.

The findings contribute to the genotype–phenotype map of DNM1L-related disease and may assist variant interpretation in clinical genomics. This preprint has not been peer-reviewed.

Plain-language version

For patients, families, and general readers. Educational only — not medical advice.

DNM1L is a gene that makes a protein called DRP1, which helps cells manage their internal power sources — structures called mitochondria — by controlling how they divide and join together. Faults in DNM1L can cause rare conditions affecting the brain and nervous system, with different types of fault causing different levels of severity. Researchers have now described four people who share the same unusual fault in a specific part of the DNM1L protein known as the GTPase effector domain. By studying cells from these individuals in the laboratory, the team found that this particular fault causes intermediate problems — more severe than the mildest known DNM1L variants, but less severe than the most serious ones. The researchers also identified a related change in how the cells process certain nutrients, which they suggest could potentially be targeted in future research. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.

Sources

Read the original reporting — these are the public sources this summary draws from.

  1. Primary sourcePreprint bioRxiv · 2026-11-04
    A DNM1L GTPase Effector Domain Deletion Causes Intermediate Defects in Peroxisomal and Mitochondrial Dynamics and Reveals a Targetable Metabolic Vulnerability

Tags

dnm1l drp1 mitochondrial-dynamics peroxisomal-dynamics rare-disease neurodevelopmental-disorders genotype-phenotype preprint
Share

About Genetic Current

Educational summaries of public genetics news

Genetic Current is the news section of Evagene, an academic, research, and educational pedigree-modelling platform. Stories are AI-drafted summaries of items from trusted public sources, written for researchers, clinicians, educators, students, genealogists, and patients with an interest in genetics. Summaries are for educational and research purposes only and are not medical advice.

Join the Evagene Alpha Waiting List